Centre grants Y category security to Serum Institute CEO Adar Poonawalla amid threats over Covishield supplies
Adar Poonawalla, the CEO of Serum Institute of India (SII) gets Y category security cover from the Centre
BusinessToday.In | April 29, 2021 | Updated 09:22 IST
CEO of Serum Institute of India Adar Poonawalla
Chief Executive Officer of the Pune-based Serum Institute of India Adar Poonawalla will get Y category security from the Centre. The Central Reserve Police Force (CRPF) will provide this security cover to Poonawalla.
This decision by the Union government came after the director, government and regulatory affairs at Serum Institute of India Prakash Kumar Singh wrote to the Union Home Minister Amit Shah on April 16.
Updated:
April 29, 2021 19:44 IST
Delhi CM Arvind Kejriwal announced on Thursday that a plan has been formulated to vaccinate all adults against coronavirus within the next three months
Share Article
AAA
COVID 19 vaccination in progress at a vaccination centre in New Delhi on Thursday .
| Photo Credit: SUSHIL KUMAR VERMA
Delhi CM Arvind Kejriwal announced on Thursday that a plan has been formulated to vaccinate all adults against coronavirus within the next three months The Delhi government will procure 67 lakh doses of Covishield vaccine from Serum Institute of India and the first tranche of three lakh shots will be delivered by May 3, official sources said on Thursday.
Bengaluru, April 28 : Karnataka on Wednesday placed an order to buy 1 crore doses of anti-Covid vaccines to inoculate adults in the 18-44 years age group
Karnataka Govt Places Order For 1 Crore Doses Of Covid-19 Vaccine To Inoculate Adults In 18-44 Age Group
by IANS - Apr 29, 2021 03:19 AM
Karnataka Chief Minister B S Yediyurappa
Karnataka on Wednesday (28 April) placed an order to buy 1 crore doses of anti-Covid vaccines to inoculate adults in the 18-44 years age group free from next month.
As the third phase of anti-Covid vaccination drive will roll out from 1 May for the 18-44 years age group, the state government has placed an order to purchase 1 crore doses, according to an official statement.
Though the order did not mention vaccine names, an official told IANS that the state would buy Covishield from the Pune-based Serum Institute of India and Covaxin from the Hyderabad-based Bharat Biotech.
A
After a tightly centralized vaccination drive that has delivered the required two shots to less than 2% of the population, India is opening up its inoculation strategy in the middle of a raging pandemic. Can the new approach flatten the curve?
Expanding the campaign to all adults below 45 starting next month is a late but welcome move. India’s daily infection rate of almost 350,000 is the worst any country has experienced. Even then, shifting a big part of the financial burden to 28 state governments and letting private hospitals buy shots at 600 to 1200 rupees ($8 to $16) apiece and sell them to patients at even higher prices are both wrong.